Free Trial
LON:NIOX

NIOX Group (NIOX) Share Price, News & Analysis

NIOX Group logo
GBX 61.40 -0.60 (-0.97%)
As of 11:56 AM Eastern

About NIOX Group Stock (LON:NIOX)

Key Stats

Today's Range
60.20
62
50-Day Range
55.90
76.04
52-Week Range
53.40
80
Volume
244,479 shs
Average Volume
1.13 million shs
Market Capitalization
£25.22 billion
P/E Ratio
2,533.87
Dividend Yield
1.63%
Price Target
GBX 90
Consensus Rating
Buy

Company Overview

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

NIOX Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

NIOX MarketRank™: 

NIOX Group scored higher than 51% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NIOX Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    NIOX Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about NIOX Group's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NIOX Group is 2,533.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NIOX Group is 2,533.87, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.18.

  • Price to Book Value per Share Ratio

    NIOX Group has a P/B Ratio of 3.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NIOX.
  • Dividend Yield

    NIOX Group pays a meaningful dividend of 1.66%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    NIOX Group does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of NIOX Group is 4,126.83%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about NIOX Group's dividend.
  • Short Interest

    There is no current short interest data available for NIOX.
  • News Sentiment

    NIOX Group has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.
  • Search Interest

    1 people have searched for NIOX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added NIOX Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NIOX Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought £10,196.32 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    46.72% of the stock of NIOX Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.23% of the stock of NIOX Group is held by institutions.

  • Read more about NIOX Group's insider trading history.
Receive NIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NIOX Group and its competitors with MarketBeat's FREE daily newsletter.

NIOX Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Niox Group Regulatory News
See More Headlines

NIOX Stock Analysis - Frequently Asked Questions

NIOX Group's stock was trading at GBX 63 at the beginning of the year. Since then, NIOX shares have decreased by 2.5% and is now trading at GBX 61.40.
View the best growth stocks for 2025 here
.

NIOX Group Plc (LON:NIOX) announced its quarterly earnings data on Tuesday, April, 1st. The company reported $2.27 EPS for the quarter. NIOX Group had a trailing twelve-month return on equity of 13.29% and a net margin of 28.21%.

Shares of NIOX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that NIOX Group investors own include Petrofac (PFC), MICT (MICT), Chemring Group (CHG) and N Brown Group (BWNG).

Company Calendar

Last Earnings
4/01/2025
Today
4/24/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:NIOX
CIK
N/A
Fax
N/A
Employees
92
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 90
High Stock Price Target
GBX 90
Low Stock Price Target
GBX 90
Potential Upside/Downside
+47.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
2,519.84
Forward P/E Ratio
52.37
P/E Growth
N/A
Net Income
£995.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.53 billion
Cash Flow
GBX 5.45 per share
Price / Cash Flow
11.21
Book Value
GBX 18.03 per share
Price / Book
3.39

Miscellaneous

Outstanding Shares
41,071,615,003
Free Float
N/A
Market Cap
£25.08 billion
Optionable
Not Optionable
Beta
0.92
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:NIOX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners